The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating notch and upregulating Akt signaling
Supplementary Figure 2: Genomic features and expression profile of T-cell lymphomas from Lck-Dlx5 mice.
(A) Trisomy 15 present in three representative thymic lymphoma T-cell lines from mice of two different Lck-Dlx5 founder lines. In addition to variable numerical and structural chromosome abnormalities, trisomy 15 is present in each cell line shown. (B) Array-CGH analysis reveals that thymic lymphoma cell lines from Lck-Dlx5 mice are of monoclonal origin. Green dots mean loss, red dots mean gain. Peaks represent loss or gain with statistical significance. Data were analyzed by using Genomic Workbench from Agilent. Note unique genomic patterns at loci for TCRα (Tcra), TCRß (Tcrb) and Ikaros zing finger (Ikzf1). used to discover Dlx5 target genes. Dlx5 was found to bind to promoter or enhancer regions of Notch1 (MACS p-value -10*LOG10 = 118.69 for downstream enhancer and MACS p-value -10*LOG10=80.56 for in gene enhancer) and Ccnd (MACS p-value -10*LOG10 = 146.73) 1. Like DLX5, DLX4 (B) and DLX6 (C) are capable of transactivating Notch1 and Notch3 via the identified enhancers as shown by luciferase reporter assay. N1P1 = Notch1 promoter 1; E1 and E2 = Notch1 enhancers; N3P1, Notch 3 promoter; E = Notch3 enhancer.
